Can we legally purchase and consume marijuana in France today? Yes and no. Yes, due to the fact that the state has actually unwinded its policies on CBD, including through the Minister of Health. And no, at the same time, due to the fact that only products containing cannabidiol (CBD), an active compound that does not have the psychoactive impacts attributed to THC, are considered legal. Let us analyze what is legal and what is not with regard to marijuana and CBD.

CBD is legal in France, however THC is not

Cannabis ought to not be confused with cannabidiol. Particularly because the second is legal in specific kinds in France … While the other is not! Since cannabidiol (known by the acronym CBD) is simply among the many active compounds from the hemp plant, which does not have the psychoactive impacts of its cousin THC – the one that makes you “stone”.

Simply put, what is normally called “marijuana”, which includes high concentrations of THC (tetrahydrocannabinol) is still considered a narcotic product. And therefore prohibited in France as in lots of countries on earth. On the other hand, marijuana which offers pride of place to the cannabinoid called cannabidiol, it is legal as long as its THC levels do not surpass 0.2%.

Nevertheless, the legislation stays vague in France on this subject. Presently, there is no law that makes it clear whether CBD is legal or not. Concretely, it is authorized for sale in the form of E-liquid, to be utilized in an electronic cigarette. However it is likewise discovered in other kinds (including oil or paste), without its purchase and usage being reprehensible … To try to make it easy, let’s say that CBD is not prohibited by French law, unlike THC

CBD vs THC.

Although CBD and THC are identical, they are very different. These are the best known of the 500 cannabinoids discovered in hemp. And each has its particular impacts. THC is especially known for its psychoactive residential or commercial properties: it causes a change in the state of consciousness by acting directly on the brain. By taking in marijuana abundant in THC, we “hover”: well-being, bliss, relaxation … But likewise red eyes, dilated pupils and, often, anxiety and even paranoia.

CBD has nothing to do with it. It is not euphoric. It does not cause anxiety or anxiety attacks. On the contrary: cannabidiol is in the procedure of making its way by virtue of its useful healing impacts. CBD assists relieve pain and swelling, minimize anxiety, alleviate the suffering of victims of anxiety attacks and depression, and even deal with specific illness (such as epilepsy or Alzheimer’s). In addition, it has a really low toxicity and presents (practically) no addicting danger, even if the lack of clinical research studies reduces these attributes to simple hypotheses.

Legalization of CBD in France: should we go even more?

Certainly, the legal progress regarding CBD is positive, however everything stays to be done. The health ministry wants to beware, and the federal government’s position on the matter looks like a balancing act. At the same time, the National Medicines Agency has actually plainly spoken out. We therefore look after the goat and the cabbage so as not to get too involved, while the vaporized cannabidiol has actually been available in France for a couple of years currently, benefiting from the legal vagueness that persists.

Beyond the 0.2% THC threshold authorized in marketed products, it ought to be remembered that only the liquid type of CBD (planned for smokeless cigarettes) is actually legal. The purchase and usage of resin or smoking herb is therefore not regulated, especially because the THC level is typically greater (around 15%). In addition, only using seeds and fibers is authorized in France. However what about one world CBD oil, which permits you to delight in the benefits of the compound without exposing your lungs to potentially harmful smoke? What about CBD paste? On these topics, there is radio silence.

In addition, composite CBD is considered a “dietary supplement”, which restricts presenting it as a medication. And make it an informed advertisement for users and clients. Too bad, due to the fact that, in the meantime, lots of prospective recipients are not benefiting from it. It is therefore needed to go even more and clarify things: more than a question of consumer well-being, it is a matter of public health.

Scroll to top